June 29, 2023, AUSTIN, Texas A Series A extension round of USD 4.5 million was raised by Heading, an insurance-based provider of mental healthcare that specializes in treating individuals with depression and trauma. Gron Ventures and Jam Fund are leading the investment, with support from Thiel Capital, Mystic Ventures, Gaingels, and Antifund, as well as the One Mind Accelerator. Thanks to this finance, heading will be able to expand into new markets and make investments in its care delivery and analytics platform.
“A divided and monolithic approach to mental health has failed patients, many of whom wait far too long to receive treatment that provides genuine and long-lasting comfort. We’re honored to have the backing of investors who share our conviction that something needs to change, said Simon Tankel, CEO & Founder of Heading. “Heading’s all-encompassing, patient-first approach is turbocharged for speedier results. The quality of life for our patients and their loved ones quickly improves thanks to personalized, combination-service care programs available through insurance policies.
For patients suffering from severe depression and trauma, Heading is a tech-enabled mental health care provider that urgently works to achieve optimal results, especially for individuals who have previously experienced failure inside the medical system. Heading clinicians prioritize treatments that have the best chance of producing positive clinical outcomes, such as Spravato®, ketamine, TMS, and, if permitted, MDMA and psilocybin. They also keep track of the most recent research and integrate it with real-time patient measurements to reduce the overall cost of care, provide value to health plan partners, and ensure that everyone who needs the best care at an affordable price has access to it.
Heading utilizes exclusive paths that combine diet, psychotherapy, and psychiatry with interventional modalities to improve patient results. There are also proposals for psychedelic treatments that are in the approval process. Heading’s staff is industry experienced in clear-minded approaches to successful mental healthcare that prioritizes impact for those who need it most, with the latest technological hire, Maxim Osipov holding a Ph.D. in Computational Psychiatry.
Heading was established in Austin in 2020, and as of 2023, it will be expanding to Dallas and Houston. It also has sites in Austin and the Dallas-Fort Worth metro area. Nearly every commercial payer in Texas, including BCBS of Texas, United Healthcare, Cigna, Aetna, and Tricare, has Heading on their list of in-network providers.
We try our best to fact-check and bring the best, well-researched, and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!